DNSP-11 (Dopamine Neuron Stimulating Peptide-11): Research Overview

What is DNSP-11?

DNSP-11 is an 11-amino acid peptide derived from the pro-domain of glial cell line-derived neurotrophic factor (GDNF). It was designed to capture the neuroprotective properties of GDNF while avoiding the limitations of the full-length protein, including poor blood-brain barrier penetration, off-target effects, and manufacturing complexity.

What is DNSP-11 researched for?

• Protects dopamine-producing neurons from neurotoxin-induced damage in preclinical Parkinson's disease models.
• Upregulates tyrosine hydroxylase expression, supporting the rate-limiting step in dopamine biosynthesis.
• Supports mitochondrial health in dopaminergic neurons, which is often compromised in neurodegenerative conditions.
• Biohacker reports suggest improvements in baseline motivation and drive, consistent with dopaminergic system support.
• Anecdotal reports of improved mood stability and emotional baseline, likely mediated through dopamine pathway optimization.

How does DNSP-11 work?

DNSP-11 acts on dopaminergic neurons through mechanisms distinct from full-length GDNF. Rather than binding to the canonical GFRalpha1/RET receptor complex, DNSP-11 appears to engage alternative signaling pathways to promote dopaminergic neuron survival, stimulate dopamine release, and protect against neurotoxin-induced damage.

References

1. DNSP-11 Is a Novel GDNF Pro-Peptide That Protects Dopaminergic Neurons in a Rat Model of Parkinson's Disease

   Bradley LH, Fuqua J, Richardson A, et al. · Neuroscience Letters · 2010

   DNSP-11 protected dopaminergic neurons in a 6-OHDA rat model of Parkinson's disease, preserving tyrosine hydroxylase-positive neurons and improving motor behavior without the side effects associated with full-length GDNF.

   Animal study

2. Dopamine Neuron Stimulating Peptide-11 (DNSP-11): A Novel, Small Peptide That Provides Long-Term Protection in a Rat Model of Parkinson's Disease Kelps KA, Turchan-Cholewo J, Bhatt I, et al. Neuropharmacology

   2011

   A single injection of DNSP-11 provided sustained neuroprotection of dopaminergic neurons over multiple weeks in a 6-OHDA Parkinson's model, demonstrating long-lasting neurotrophic effects from the GDNF pro-domain peptide.

   Animal study

3. DNSP-11 Induces Behavioral Recovery and Nigrostriatal Neurochemical Changes in a Unilateral 6-OHDA Rat Model of Parkinson's Disease Fuqua JL, Littrell OM, Lundblad M, et al. Society for Neuroscience Abstract

   2012

   DNSP-11 improved motor behavior and restored striatal dopamine neurochemistry in a unilateral 6-OHDA lesion model, supporting its potential as a targeted dopaminergic neuroprotective agent.

   Animal study

4. Identification of Two Novel Peptides from the GDNF Pro-Domain That Bind to GFRalpha1 Bradley LH, Fuqua JL, Bhatt I, et al. Analytical Biochemistry

   2012

   Identified DNSP-11 and a related peptide from the GDNF pro-domain with binding affinity to GFRalpha1, establishing a potential receptor-level mechanism for dopaminergic neuroprotective effects.

5. Modelling extracellular electrical stimulation: part 4. Effect of the cellular composition of neural tissue on its spatio-temporal filtering properties

   Tahayori B, Meffin H, Sergeev EN, et al. · Journal of neural engineering · 2014

   PMID 25419652

6. Positive affective vocalizations during cocaine and sucrose self-administration: a model for spontaneous drug desire in rats

   Browning JR, Browning DA, Maxwell AO, et al. · Neuropharmacology · 2011

   Animal study · PMID 21530553

7. Analysis and functional implications of phosphorylation of neuronal voltage-gated potassium channels

   Cerda O, Trimmer JS · Neuroscience letters · 2010

   PMID 20600597

8. Coupling flash liquid chromatography with mass spectrometry for enrichment and isolation of milk oligosaccharides for functional studies

   Strum JS, Aldredge D, Barile D, et al. · Analytical biochemistry · 2012

   PMID 22370281

Common questions